サイト内検索


登録済み会員ログイン




未登録の方はこちらから登録できます。
新規会員登録


ご利用案内

ご利用案内


連絡先

TEL.03-5812-5270
FAX.03-3831-0495
E-mail:info@spi-information.com


関連サイト・サービス

市場調査のご依頼、専門分野のイベント・フォーラムの開催などは シード・プランニングにて承っております。

シードプランニング

世界の医療・医薬品産業レポートのデータベースサービスは、sekairyo.comにてご利用いただけます。

sekairyo.com

医療従事者へのあらゆる形態の調査は、メドサークルにお任せ下さい。

メドサークル


セキュリティについて

当サイトのコンテンツ利用時に送信される機密情報は、Verisign認証の元暗号化されて送信されます。


Preclinical CRO Market Research Report – Global Forecast till 2023

前臨床CRO市場調査レポート−2023年までの世界予測

レポート概要

世界の前臨床CRO市場調査レポート:サービス別(生体分析&DMPK試験、毒性試験)、治療分野別(オンコロジー、糖尿病)、エンドユーザー別(医薬品&バイオ医薬品産業、医療機器メーカー)−2023年までの予測

市場シナリオ

世界の前臨床CRO市場は2017年に44億5,020ドル、予測期間中のCAGRは6.6%と推定されます。前臨床CROは医薬品や医療機器を臨床段階からマーケティングまたは流通段階に進めるために必要な経験、知識、スキルを提供します。前臨床CROはプロトコルデザインから臨床データの提出に至るまでの前臨床試験サービスを遂行します。前臨床CRO市場をけん引する要因としては、ライフサイエンス企業が自社のコアコンピタンスを重視する傾向にあること、主力以外の業務の外注が増加していること、研究開発費の増加、前臨床フェーズにある医薬品の急増などが挙げられます。

例えばEvaluatePharmaによると、2010年から2012年までに約650億ドルの価値を有する先発医薬品が特許切れを迎えたことから、医薬品メーカーは新薬の承認数が増加傾向にあります。その一方で、生物製剤&バイオシミラー市場の成長や専門的な試験サービスの需要の増加によって予測期間中はこの市場の拡大を阻害する可能性があります。

レポート詳細

目次

Table of Contents:

Chapter 1 Report Prologue

Chapter 2 Executive Summary

Chapter 3 Market Introduction
3.1 Definition
3.2 Scope of the Study
3.2.1 Research Objective
3.2.2 Assumptions
3.2.3 Limitations

Chapter 4 Research Methodology
4.1 Introduction
4.2 Primary Research
4.3 Secondary Research
4.4 Market Size Estimation

Chapter 5 Market Dynamics
5.1 Drivers
5.2 Restraints
5.3 Opportunities
5.4 Challenges
5.5 Macroeconomic Indicators
5.6 Detection Technique Trends & Assessment

Chapter 6 Market Factor Analysis
6.1 Porter’s Five Forces Analysis
6.1.1 Bargaining Power of Suppliers
6.1.2 Bargaining Power of Buyers
6.1.3 Threat of New Entrants
6.1.4 Threat of Substitutes
6.1.5 Intensity of Rivalry
6.2 Value Chain Analysis
6.3 Investment Feasibility Analysis
6.4 Pricing Analysis

Chapter 7 Global Preclinical CRO Market, by Service
7.1 Introduction
7.2 Bioanalysis & Drug Metabolism and Pharmacokinetics (DMPK) Studies
Market Estimates & Forecast, by Region, 2018-2023
Market Estimates & Forecast, by Country, 2018-2023
7.3 Toxicology Testing
Market Estimates & Forecast, by Region, 2018-2023
Market Estimates & Forecast, by Country, 2018-2023
7.4 Others
Market Estimates & Forecast, by Region, 2018-2023
Market Estimates & Forecast, by Country, 2018-2023

Chapter 8 Global Preclinical CRO Market, by Therapeutic Area
8.1 Introduction
8.2 Oncology
Market Estimates & Forecast, by Region, 2018-2023
Market Estimates & Forecast, by Country, 2018-2023
8.3 Diabetes
Market Estimates & Forecast, by Region, 2018-2023
Market Estimates & Forecast, by Country, 2018-2023
8.4 Infectious Diseases
Market Estimates & Forecast, by Region, 2018-2023
Market Estimates & Forecast, by Country, 2018-2023
8.5 Immunological Disorders
Market Estimates & Forecast, by Region, 2018-2023
Market Estimates & Forecast, by Country, 2018-2023
8.6 Cardiovascular Diseases
Market Estimates & Forecast, by Region, 2018-2023
Market Estimates & Forecast, by Country, 2018-2023
8.7 Respiratory Diseases
Market Estimates & Forecast, by Region, 2018-2023
Market Estimates & Forecast, by Country, 2018-2023
8.8 Others
Market Estimates & Forecast, by Region, 2018-2023
Market Estimates & Forecast, by Country, 2018-2023

Chapter 9 Global Preclinical CRO Market, by End User
9.1 Pharmaceutical & Biopharmaceutical Industries
Market Estimates & Forecast, by Region, 2018-2023
Market Estimates & Forecast, by Country, 2018-2023
9.2 Medical Device Companies
Market Estimates & Forecast, by Region, 2018-2023
Market Estimates & Forecast, by Country, 2018-2023
9.3 Academic Institutes
Market Estimates & Forecast, by Region, 2018-2023
Market Estimates & Forecast, by Country, 2018-2023

Chapter 10 Global Preclinical CRO Market, by Region
10.1 Introduction
10.2 Americas
10.2.1 North America
10.2.1.1 US
10.2.1.2 Canada
10.2.2 Latin America
10.3 Europe
10.3.1 Western Europe
10.3.1.1 Germany
10.3.1.2 France
10.3.1.3 Italy
10.3.1.4 Spain
10.3.1.5 UK
10.3.1.6 Rest of Western Europe
10.3.2 Eastern Europe
10.4 Asia-Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 South Korea
10.4.6 Rest of Asia-Pacific
10.5 Middle East & Africa
10.5.1 Middle East
10.5.2 Africa

Chapter 11 Company Landscape
11.1 Introduction
11.2 Market Share Analysis
11.3 Key Developments & Strategies

Chapter 12 Company Profiles
12.1 IQVIA
12.1.1 Company Overview
12.1.2 Product Overview
12.1.3 Financials Overview
12.1.4 Key Developments
12.1.5 SWOT Analysis
12.1.6 Key Strategies
12.2 PAREXEL International Corporation
12.2.1 Company Overview
12.2.2 Product Overview
12.2.3 Financials Overview
12.2.4 Key Developments
12.2.5 SWOT Analysis
12.2.6 Key Strategies
12.3 Envigo
12.3.1 Company Overview
12.3.2 Product Overview
12.3.3 Financials Overview
12.3.4 Key Developments
12.3.5 SWOT Analysis
12.3.6 Key Strategies
12.4 Charles River
12.4.1 Company Overview
12.4.2 Product Overview
12.4.3 Financials Overview
12.4.4 Key Developments
12.4.5 SWOT Analysis
12.4.6 Key Strategies
12.5 Eurofins Scientific
12.5.1 Company Overview
12.5.2 Product Overview
12.5.3 Financials Overview
12.5.4 Key Developments
12.5.5 SWOT Analysis
12.5.6 Key Strategies
12.6 ICON plc
12.6.1 Company Overview
12.6.2 Product Overview
12.6.3 Financials Overview
12.6.4 Key Developments
12.6.5 SWOT Analysis
12.6.6 Key Strategies
12.7 PRA Health Sciences (PRA)
12.7.1 Company Overview
12.7.2 Product Overview
12.7.3 Financials Overview
12.7.4 Key Developments
12.7.5 SWOT Analysis
12.7.6 Key Strategies
12.8 Medpace
12.8.1 Company Overview
12.8.2 Product Overview
12.8.3 Financials Overview
12.8.4 Key Developments
12.8.5 SWOT Analysis
12.8.6 Key Strategies
12.9 Laboratory Corporation of America Holdings
12.9.1 Company Overview
12.9.2 Product Overview
12.9.3 Financials Overview
12.9.4 Key Developments
12.9.5 SWOT Analysis
12.9.6 Key Strategies
12.10 Pharmaceutical Product Development, LLC
12.10.1 Company Overview
12.10.2 Product Overview
12.10.3 Financials Overview
12.10.4 Key Developments
12.10.5 SWOT Analysis
12.10.6 Key Strategies
12.11 WuXi AppTec
12.11.1 Company Overview
12.11.2 Product Overview
12.11.3 Financials Overview
12.11.4 Key Developments
12.11.5 SWOT Analysis
12.11.6 Key Strategies
12.12 MD Biosciences
12.12.1 Company Overview
12.12.2 Product Overview
12.12.3 Financials Overview
12.12.4 Key Developments
12.12.5 SWOT Analysis
12.12.6 Key Strategies

Chapter 13 MRFR Conclusion
13.1 Key Findings
13.1.1 From CEO’s View point
13.1.2 Unmet Needs of the Market
13.2 Key Companies to Watch
13.3 Predictions for the Preclinical CRO Industry

Chapter 14 Appendix

LIST OF TABLES
Table 1 Global Preclinical CRO Market Synopsis, 2018-2023
Table 2 Global Preclinical CRO Market Estimates and Forecast, 2018-2023 (USD Million)
Table 3 Global Preclinical CRO Market, by Region, 2018-2023 (USD Million)
Table 4 Global Preclinical CRO Market, by Service, 2018-2023 (USD Million)
Table 5 Global Preclinical CRO Market, by Therapeutic Area, 2018-2023 (USD Million)
Table 6 Global Preclinical CRO Market, by End User, 2018-2023 (USD Million)
Table 7 North America: Preclinical CRO Market, by Service, 2018-2023 (USD Million)
Table 8 North America: Preclinical CRO Market, by Therapeutic Area, 2018-2023 (USD Million)
Table 9 North America: Preclinical CRO Market, by End User, 2018-2023 (USD Million)
Table 10 US: Preclinical CRO Market, by Service, 2018-2023 (USD Million)
Table 11 US: Preclinical CRO Market, by Therapeutic Area, 2018-2023 (USD Million)
Table 12 US: Preclinical CRO Market, by End User, 2018-2023 (USD Million)
Table 13 Canada: Preclinical CRO Market, by Service, 2018-2023 (USD Million)
Table 14 Canada: Preclinical CRO Market, by Therapeutic Area, 2018-2023 (USD Million)
Table 15 Canada: Preclinical CRO Market, by End User, 2018-2023 (USD Million)
Table 16 Latin America: Preclinical CRO Market, by Service, 2018-2023 (USD Million)
Table 17 Latin America: Preclinical CRO Market, by Therapeutic Area, 2018-2023 (USD Million)
Table 18 Latin America: Preclinical CRO Market, by End User, 2018-2023 (USD Million)
Table 19 Europe: Preclinical CRO Market, by Service, 2018-2023 (USD Million)
Table 20 Europe: Preclinical CRO Market, by Therapeutic Area, 2018-2023 (USD Million)
Table 21 Europe: Preclinical CRO Market, by End User, 2018-2023 (USD Million)
Table 22 Western Europe: Preclinical CRO Market, by Service, 2018-2023 (USD Million)
Table 23 Western Europe: Preclinical CRO Market, by Therapeutic Area, 2018-2023 (USD Million)
Table 24 Western Europe: Preclinical CRO Market, by End User, 2018-2023 (USD Million)
Table 25 Eastern Europe: Preclinical CRO Market, by Service, 2018-2023 (USD Million)
Table 26 Eastern Europe: Preclinical CRO Market, by Therapeutic Area, 2018-2023 (USD Million)
Table 27 Eastern Europe: Preclinical CRO Market, by End User, 2018-2023 (USD Million)
Table 28 Asia-Pacific: Preclinical CRO Market, by Service, 2018-2023 (USD Million)
Table 29 Asia-Pacific: Preclinical CRO Market, by Therapeutic Area, 2018-2023 (USD Million)
Table 30 Asia-Pacific: Preclinical CRO Market, by End User, 2018-2023 (USD Million)
Table 31 Middle East & Africa: Preclinical CRO Market, by Service, 2018-2023 (USD Million)
Table 32 Middle East & Africa: Preclinical CRO Market, by Therapeutic Area, 2018-2023 (USD Million)
Table 33 Middle East & Africa: Preclinical CRO Market, by End User, 2018-2023 (USD Million)

LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation for Global Preclinical CRO Market
Figure 3 Segmentation Market Dynamics for Global Preclinical CRO Market
Figure 4 Global Preclinical CRO Market Share, by Service, 2017
Figure 5 Global Preclinical CRO Market Share, by Therapeutic Area, 2017
Figure 6 Global Preclinical CRO Market Share, by End User, 2017
Figure 7 Global Preclinical CRO Market Share, by Region, 2017
Figure 8 North America: Preclinical CRO Market Share, by Country, 2017
Figure 9 Europe: Preclinical CRO Market Share, by Country, 2017
Figure 10 Asia-Pacific: Preclinical CRO Market Share, by Country, 2017
Figure 11 Middle East & Africa: Preclinical CRO Market Share, by Country, 2017
Figure 12 Global Preclinical CRO Market: Company Share Analysis, 2017 (%)
Figure 13 IQVIA: Key Financials
Figure 14 IQVIA: Segmental Revenue
Figure 15 IQVIA: Geographical Revenue
Figure 16 PAREXEL International Corporation: Key Financials
Figure 17 PAREXEL International Corporation: Segmental Revenue
Figure 18 PAREXEL International Corporation: Geographical Revenue
Figure 19 Envigo: Key Financials
Figure 20 Envigo: Segmental Revenue
Figure 21 Envigo: Geographical Revenue
Figure 22 Charles River: Key Financials
Figure 23 Charles River: Segmental Revenue
Figure 24 Charles River: Geographical Revenue
Figure 25 Eurofins Scientific: Key Financials
Figure 26 Eurofins Scientific: Segmental Revenue
Figure 27 Eurofins Scientific: Geographical Revenue
Figure 28 ICON plc: Key Financials
Figure 29 ICON plc: Segmental Revenue
Figure 30 ICON plc: Geographical Revenue
Figure 31 PRA Health Sciences (PRA): Key Financials
Figure 32 PRA Health Sciences (PRA): Segmental Revenue
Figure 33 PRA Health Sciences (PRA): Geographical Revenue
Figure 34 Medpace: Key Financials
Figure 35 Medpace: Segmental Revenue
Figure 36 Medpace: Geographical Revenue
Figure 37 Laboratory Corporation of America Holdings: Key Financials
Figure 38 Laboratory Corporation of America Holdings: Segmental Revenue
Figure 39 Laboratory Corporation of America Holdings: Geographical Revenue
Figure 40 Pharmaceutical Product Development, LLC: Key Financials
Figure 41 Pharmaceutical Product Development, LLC: Segmental Revenue
Figure 42 Pharmaceutical Product Development, LLC: Geographical Revenue
Figure 43 WuXi AppTec: Key Financials
Figure 44 WuXi AppTec: Segmental Revenue
Figure 45 WuXi AppTec: Geographical Revenue
Figure 46 MD Biosciences: Key Financials
Figure 47 MD Biosciences: Segmental Revenue
Figure 48 MD Biosciences: Geographical Revenue

発刊日

2019/01

体裁

PDF / 90ページ

販売価格

4,450USD

発行

Market Research Future

備考

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※販売価格はシングルユーザーライセンスのものとなります。他のライセンス形態・価格に関しましてはご相談下さい。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

関連カテゴリ

医薬品原料・製剤 / アウトソーシング

購入・お問い合わせ

このレポートを購入

詳細を問い合わせる


PAGE